AbbVie agreed to pay up to $1.2 billion to buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major ...

If you or someone you know may be considering suicide, contact the 988 Suicide & Crisis Lifeline: call or text 988 or chat ...

The comments related to financial challenges included references to their own or others’ grants being terminated, delays in ...

CEO Jacob Thaysen sees Illumina on track to meet his original goal of high single-digit revenue growth by 2027 despite ...

Hospice care cannot achieve its mission unless it actively addresses the inequities built into the structures around it.

AbbVie said it will buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression, a sign that ...

HHS is terminating a National Institutes of Health grant program that supports students from marginalized backgrounds in the ...

A person who traveled to El Salvador has been diagnosed with New World screwworm — the first reported U.S. case tied to ...

The results suggest that lung xenotransplantation could one day become an option, but they also point to how much more work ...

The FDA has begun publishing reports of adverse events concerning drugs and biological products on a daily basis ...

Amid demand for retraction, a leading medical journal is reviewing a discredited study published in 2001 that touted the ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...